Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01733004
Title A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merrimack Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA


No variant requirements are available.